Antinociceptive interaction of gabapentin with minocycline in murine diabetic neuropathy

H. F. Miranda, F. Sierralta, V. Jorquera, P. Poblete, J. C. Prieto, V. Noriega

Resultado de la investigación: Article

7 Citas (Scopus)

Resumen

Objective: Diabetic neuropathy (DN) is the most common complication of diabetes and pain is one of the main symptoms of diabetic neuropathy, however, currently available drugs are often ineffective and complicated by adverse events. The purpose of this research was to evaluate the antinociceptive interaction between gabapentin and minocycline in a mice experimental model of DN by streptozocin (STZ). Methods: The interaction of gabapentin with minocycline was evaluated by the writhing and hot plate tests at 3 and 7 days after STZ injection or vehicle in male CF1 mice. Results: STZ (150 mg/kg, i.p.) produced a marked increase in plasma glucose levels on day 7 (397.46 ± 29.65 mg/dL) than on day 3 (341.12 ± 35.50 mg/dL) and also developed neuropathic pain measured by algesiometric assays. Gabapentin produced similar antinociceptive activity in both writhing and hot plate tests in mice pretreated with STZ. However, minocycline was more potent in the writhing than in the hot plate test in the same type of mice. The combination of gabapentin with minocycline produced synergistic interaction in both test. Conclusion: The combination of gabapentin with minocycline in a 1:1 proportion fulfills all the criteria of multimodal analgesia and this finding suggests that the combination provide a therapeutic alternative that could be used for human neuropathic pain management.

Idioma originalEnglish
Páginas (desde-hasta)91-97
Número de páginas7
PublicaciónInflammopharmacology
Volumen25
N.º1
DOI
EstadoPublished - 1 feb 2017

Huella dactilar

Minocycline
Diabetic Neuropathies
Streptozocin
Neuralgia
Diabetes Complications
Pain Management
Analgesia
Theoretical Models
gabapentin
Glucose
Pain
Injections
Research
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Immunology
  • Pharmacology
  • Pharmacology (medical)

Citar esto

Miranda, H. F., Sierralta, F., Jorquera, V., Poblete, P., Prieto, J. C., & Noriega, V. (2017). Antinociceptive interaction of gabapentin with minocycline in murine diabetic neuropathy. Inflammopharmacology, 25(1), 91-97. https://doi.org/10.1007/s10787-017-0308-5
Miranda, H. F. ; Sierralta, F. ; Jorquera, V. ; Poblete, P. ; Prieto, J. C. ; Noriega, V. / Antinociceptive interaction of gabapentin with minocycline in murine diabetic neuropathy. En: Inflammopharmacology. 2017 ; Vol. 25, N.º 1. pp. 91-97.
@article{628a8e5d8f944ac08afd98c50222e025,
title = "Antinociceptive interaction of gabapentin with minocycline in murine diabetic neuropathy",
abstract = "Objective: Diabetic neuropathy (DN) is the most common complication of diabetes and pain is one of the main symptoms of diabetic neuropathy, however, currently available drugs are often ineffective and complicated by adverse events. The purpose of this research was to evaluate the antinociceptive interaction between gabapentin and minocycline in a mice experimental model of DN by streptozocin (STZ). Methods: The interaction of gabapentin with minocycline was evaluated by the writhing and hot plate tests at 3 and 7 days after STZ injection or vehicle in male CF1 mice. Results: STZ (150 mg/kg, i.p.) produced a marked increase in plasma glucose levels on day 7 (397.46 ± 29.65 mg/dL) than on day 3 (341.12 ± 35.50 mg/dL) and also developed neuropathic pain measured by algesiometric assays. Gabapentin produced similar antinociceptive activity in both writhing and hot plate tests in mice pretreated with STZ. However, minocycline was more potent in the writhing than in the hot plate test in the same type of mice. The combination of gabapentin with minocycline produced synergistic interaction in both test. Conclusion: The combination of gabapentin with minocycline in a 1:1 proportion fulfills all the criteria of multimodal analgesia and this finding suggests that the combination provide a therapeutic alternative that could be used for human neuropathic pain management.",
keywords = "Diabetes, Gabapentin, Minocycline, Neuropathy, Streptozocin, Synergism",
author = "Miranda, {H. F.} and F. Sierralta and V. Jorquera and P. Poblete and Prieto, {J. C.} and V. Noriega",
year = "2017",
month = "2",
day = "1",
doi = "10.1007/s10787-017-0308-5",
language = "English",
volume = "25",
pages = "91--97",
journal = "Inflammopharmacology",
issn = "0925-4692",
publisher = "Birkhauser Verlag Basel",
number = "1",

}

Miranda, HF, Sierralta, F, Jorquera, V, Poblete, P, Prieto, JC & Noriega, V 2017, 'Antinociceptive interaction of gabapentin with minocycline in murine diabetic neuropathy', Inflammopharmacology, vol. 25, n.º 1, pp. 91-97. https://doi.org/10.1007/s10787-017-0308-5

Antinociceptive interaction of gabapentin with minocycline in murine diabetic neuropathy. / Miranda, H. F.; Sierralta, F.; Jorquera, V.; Poblete, P.; Prieto, J. C.; Noriega, V.

En: Inflammopharmacology, Vol. 25, N.º 1, 01.02.2017, p. 91-97.

Resultado de la investigación: Article

TY - JOUR

T1 - Antinociceptive interaction of gabapentin with minocycline in murine diabetic neuropathy

AU - Miranda, H. F.

AU - Sierralta, F.

AU - Jorquera, V.

AU - Poblete, P.

AU - Prieto, J. C.

AU - Noriega, V.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Objective: Diabetic neuropathy (DN) is the most common complication of diabetes and pain is one of the main symptoms of diabetic neuropathy, however, currently available drugs are often ineffective and complicated by adverse events. The purpose of this research was to evaluate the antinociceptive interaction between gabapentin and minocycline in a mice experimental model of DN by streptozocin (STZ). Methods: The interaction of gabapentin with minocycline was evaluated by the writhing and hot plate tests at 3 and 7 days after STZ injection or vehicle in male CF1 mice. Results: STZ (150 mg/kg, i.p.) produced a marked increase in plasma glucose levels on day 7 (397.46 ± 29.65 mg/dL) than on day 3 (341.12 ± 35.50 mg/dL) and also developed neuropathic pain measured by algesiometric assays. Gabapentin produced similar antinociceptive activity in both writhing and hot plate tests in mice pretreated with STZ. However, minocycline was more potent in the writhing than in the hot plate test in the same type of mice. The combination of gabapentin with minocycline produced synergistic interaction in both test. Conclusion: The combination of gabapentin with minocycline in a 1:1 proportion fulfills all the criteria of multimodal analgesia and this finding suggests that the combination provide a therapeutic alternative that could be used for human neuropathic pain management.

AB - Objective: Diabetic neuropathy (DN) is the most common complication of diabetes and pain is one of the main symptoms of diabetic neuropathy, however, currently available drugs are often ineffective and complicated by adverse events. The purpose of this research was to evaluate the antinociceptive interaction between gabapentin and minocycline in a mice experimental model of DN by streptozocin (STZ). Methods: The interaction of gabapentin with minocycline was evaluated by the writhing and hot plate tests at 3 and 7 days after STZ injection or vehicle in male CF1 mice. Results: STZ (150 mg/kg, i.p.) produced a marked increase in plasma glucose levels on day 7 (397.46 ± 29.65 mg/dL) than on day 3 (341.12 ± 35.50 mg/dL) and also developed neuropathic pain measured by algesiometric assays. Gabapentin produced similar antinociceptive activity in both writhing and hot plate tests in mice pretreated with STZ. However, minocycline was more potent in the writhing than in the hot plate test in the same type of mice. The combination of gabapentin with minocycline produced synergistic interaction in both test. Conclusion: The combination of gabapentin with minocycline in a 1:1 proportion fulfills all the criteria of multimodal analgesia and this finding suggests that the combination provide a therapeutic alternative that could be used for human neuropathic pain management.

KW - Diabetes

KW - Gabapentin

KW - Minocycline

KW - Neuropathy

KW - Streptozocin

KW - Synergism

UR - http://www.scopus.com/inward/record.url?scp=85011593447&partnerID=8YFLogxK

U2 - 10.1007/s10787-017-0308-5

DO - 10.1007/s10787-017-0308-5

M3 - Article

AN - SCOPUS:85011593447

VL - 25

SP - 91

EP - 97

JO - Inflammopharmacology

JF - Inflammopharmacology

SN - 0925-4692

IS - 1

ER -